Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 11:59 am Purchase | 2024-12-31 | 13G | Precision BioSciences, Inc. DTIL | Aquilo Capital Management LLC | 791,862 9.900% | 791,862 (New Position) | Filing History |
| 2024-03-18 5:28 pm Purchase | 2024-03-01 | 13G | Precision BioSciences, Inc. DTIL | Aquilo Capital Management LLC | 662,659 9.900% | 662,659 (New Position) | Filing History |
| 2024-02-14 4:37 pm Sale | 2023-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Aquilo Capital Management LLC | 14,085 1.100% | -56,911 (-80.16%) | Filing History |
| 2023-02-14 11:28 am Purchase | 2022-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Aquilo Capital Management LLC | 70,995 7.500% | 16,954 (+31.37%) | Filing History |
| 2023-02-14 11:16 am Sale | 2022-12-31 | 13G | Spero Therapeutics, Inc. SPRO | Aquilo Capital Management LLC | 0 0.000% | -3,419,435 (Position Closed) | Filing History |
| 2023-02-14 11:12 am Sale | 2022-12-31 | 13G | Magenta Therapeutics, Inc. MGTA | Aquilo Capital Management LLC | 0 0.000% | -3,155,082 (Position Closed) | Filing History |
| 2022-10-03 4:40 pm Sale | 2022-09-22 | 13G | Spero Therapeutics, Inc. SPRO | Aquilo Capital Management LLC | 3,419,435 9.800% | -1,602,101 (-31.90%) | Filing History |
| 2022-03-08 5:41 pm Purchase | 2022-01-18 | 13G | Spero Therapeutics, Inc. SPRO | Aquilo Capital Management LLC | 5,021,536 15.500% | 57,355 (+1.16%) | Filing History |
| 2022-02-14 3:54 pm Purchase | 2021-12-31 | 13G | Spero Therapeutics, Inc. SPRO | Aquilo Capital Management LLC | 4,964,181 15.400% | 1,031,972 (+26.24%) | Filing History |
| 2022-02-14 3:20 pm Sale | 2021-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Aquilo Capital Management LLC | 54,041 5.900% | -5,988 (-9.97%) | Filing History |
| 2022-02-14 3:09 pm Purchase | 2021-12-31 | 13G | Magenta Therapeutics, Inc. MGTA | Aquilo Capital Management LLC | 3,155,082 5.400% | 3,155,082 (New Position) | Filing History |
| 2021-02-16 4:13 pm Sale | 2020-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Aquilo Capital Management LLC | 60,029 8.400% | -9,665 (-13.87%) | Filing History |
| 2021-02-16 4:00 pm Sale | 2020-12-31 | 13G | Spero Therapeutics, Inc. SPRO | Aquilo Capital Management LLC | 3,932,209 14.500% | -564,933 (-12.56%) | Filing History |
| 2020-09-22 6:51 pm Purchase | 2020-09-11 | 13G | Spero Therapeutics, Inc. SPRO | Aquilo Capital Management LLC | 4,497,142 17.400% | 3,342,786 (+289.58%) | Filing History |
| 2020-04-21 7:42 pm Purchase | 2020-03-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Aquilo Capital Management LLC | 69,694 10.100% | 315 (+0.45%) | Filing History |